Liposem Tablets — Saroglitazar 2 mg (30 Tabs) Everest
Liposem 2 mg (Saroglitazar Magnesium) is an innovative dual PPAR (peroxisome proliferator-activated receptor) alpha and gamma agonist. Its unique mechanism of action targets both lipid and glycemic parameters. It effectively lowers high triglyceride levels while simultaneously improving insulin sensitivity to help control blood sugar.
Manufacturer: Everest Pharmaceuticals (Bangladesh). This medication represents a significant advancement in treating metabolic disorders and is highly effective in reversing fatty liver conditions.
Key Features:
- ✅ Dual Action: Manages both hypertriglyceridemia (high blood fats) and hyperglycemia in Type 2 Diabetes.
- ✅ Liver Health: Clinically proven to treat Non-Alcoholic Fatty Liver Disease (NAFLD) by reducing liver fat and inflammation.
- ✅ Cardiovascular Protection: Helps lower the risk of cardiovascular events in patients with metabolic syndrome.
Prescribed by an endocrinologist, cardiologist, or hepatologist for the following conditions:
- 🔹 Diabetic Dyslipidemia: High triglyceride levels in patients with Type 2 Diabetes, particularly when statin therapy alone is insufficient.
- 🔹 Non-Alcoholic Fatty Liver Disease (NAFLD): And Non-Alcoholic Steatohepatitis (NASH) — to reduce hepatic fat accumulation and prevent fibrosis progression.
Sales Unit: Carton box containing 3 blister packs of 10 tablets each (total 30 tablets). Strength: 2 mg per tablet.
⚠️ APPLICATION INSTRUCTIONS:
- Standard Dosage: The usual recommended dose for adults is 4 mg (two 2 mg tablets) taken once daily. Always follow your doctor's specific prescription!
- Administration: Take orally, preferably in the morning, with or without food. Swallow whole with a glass of water.
- Duration: Intended for long-term use. Regular monitoring of lipid profiles and liver function tests is recommended.
- ⛔ Type 1 Diabetes: Not indicated for the treatment of Type 1 Diabetes.
- Heart failure (especially severe stages).
- Pregnancy and breastfeeding.
- Severe hepatic or renal impairment.
- Children and adolescents under 18 years of age.
Saroglitazar is generally well tolerated. Potential side effects include:
- 🤢 Gastrointestinal: Gastritis, dyspepsia (indigestion).
- 💤 General: Asthenia (weakness, fatigue).
- 💧 Metabolic: Fluid retention (peripheral edema), slight weight gain.
- 🔶 Laboratory: Rare and transient elevation of liver enzymes (requires monitoring).
Similar products
What Customers Say
No reviews yet
Your review can be the first!